Pretreatment SUV(max) predicts progression-free survival in early-stage non-small cell lung cancer treated with stereotactic body radiation therapy

BACKGROUND: This retrospective study aims to assess the usefulness of SUV(max) from FDG-PET imaging as a prognosticator for primary biopsy-proven stage I NSCLC treated with SBRT. METHODS: This study includes 95 patients of median age 77 years, with primary, biopsy-confirmed peripheral stage IA/IB NS...

Descripción completa

Detalles Bibliográficos
Autores principales: Horne, Zachary D, Clump, David A, Vargo, John A, Shah, Samir, Beriwal, Sushil, Burton, Steven A, Quinn, Annette E, Schuchert, Matthew J, Landreneau, Rodney J, Christie, Neil A, Luketich, James D, Heron, Dwight E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922961/
https://www.ncbi.nlm.nih.gov/pubmed/24479954
http://dx.doi.org/10.1186/1748-717X-9-41

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922961/
https://www.ncbi.nlm.nih.gov/pubmed/24479954
http://dx.doi.org/10.1186/1748-717X-9-41

Ejemplares similares